Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

Zhao, Shimin, Lin, Yan, Xu, Wei, Jiang, Wenqing, Zha, Zhengyu, Wang, Pu, Yu, Wei, Li, Zhiqiang +6 more·2009·Science

DOI 10.1126/science.1170944

Cited by (1,000)

Items 101–200 of 1,000

Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
Sameer Agnihotri, Kelly E. Burrell, Amparo Wolf, Sharzhad Jalali, Cynthia E Hawkins, James T. Rutka, Gelareh Mohammed Zadeh · 2012 · Archivum Immunologiae et Therapiae Experimentalis
L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH
Intlekofer, Andrew M, Wang, Bo, Liu, Hui, Shah, Hardik, Carmona-Fontaine, Carlos, Rustenburg, Ariën S, Salah, Salah, Gunner, M R, Chodera, John D, Cross, Justin R et al. · 2017 · Nature Chemical Biology
bHLH-PAS proteins in cancer
Bersten, David C., Sullivan, Adrienne E., Peet, Daniel J., Whitelaw, Murray L. · 2013 · Nature Reviews Cancer
Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1
Jean‐Sébastien Joyal, Ye Sun, Marin L. Gantner, Zhuo Shao, Lucy P. Evans, Nicholas Saba, Thomas W Fredrick, Samuel B. Burnim, Jin Sung Kim, Gauri Patel et al. · 2016 · Nature Medicine
Mutational Heterogeneity in Human Cancers: Origin and Consequences
Jesse J. Salk, Edward Fox, Lawrence A. Loeb · 2009 · Annual Review of Pathology Mechanisms of Disease
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
Guanzhong Qiu, Mingzhu Jin, Jinxiang Dai, Wei Sun, Jihong Feng, Weilin Jin · 2017 · Trends in Pharmacological Sciences
NADP+-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance
Li, Feng, He, Xiadi, Ye, Dingwei, Lin, Yan, Yu, Hongxiu, Yao, Cuifang, Huang, Lei, Zhang, Jianong, Wang, Fang, Xu, Sha et al. · 2015 · Molecular Cell
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Ye, Dan, Guan, Kun-Liang, Xiong, Yue · 2018 · Trends in Cancer
Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor
Katharina Wagner, Frédérik Damm, Gudrun Göhring, Kerstin Görlich, Michael Heuser, Irina Schäfer, Oliver Gerhard Ottmann, Michael Lübbert, Wolfgang F.W. Heit, Lothar Kanz et al. · 2010 · Journal of Clinical Oncology
Targeting mutations in cancer
Michael R. Waarts, Aaron James Stonestrom, Young C. Park, Ross L. Levine · 2022 · Journal of Clinical Investigation
Molecular subclassification of diffuse gliomas: Seeing order in the chaos
Jason T. Huse, HEIDI S. PHILLIPS, Cameron Walter Brennan · 2011 · Glia
Mitochondria in cancer
Debora Grasso, Luca X. Zampieri, Tânia Capelôa, Justine A. Van de Velde, Pierre Sonveaux · 2020 · Cell Stress
Molecular and Genomic Alterations in Glioblastoma Multiforme
Crespo, Ines, Vital, Ana Louisa, Gonzalez-Tablas, María, Patino, María del Carmen, Otero, Alvaro, Lopes, María Celeste, de Oliveira, Catarina, Domingues, Patricia, Orfao, Alberto, Tabernero, Maria Dolores · 2015 · The American Journal of Pathology
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study
Maeve Aine Lowery, Howard A. Burris, Filip Jankú, Rachna T. Shroff, James M. Cleary, Nilofer Saba Azad, Lipika Goyal, Elizabeth Anne Maher, Lia Gore, Antoine Hollebecque et al. · 2019 · The Lancet. Gastroenterology & hepatology
IDH Mutation in Glioma
Zorbey T. Turkalp, Jason Karamchandani, Sunit Das · 2014 · JAMA Neurology
Isocitrate dehydrogenase-1 mutations: A fundamentally new understanding of diffuse glioma?
Kloosterhof, Nanne K, Bralten, Linda BC, Dubbink, Hendrikus J, French, Pim J, van den Bent, Martin J · 2011 · The Lancet Oncology
Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Nicolas Boissel, Olivier Nibourel, Aline Renneville, Claude Gardin, Oumédaly Reman, Nathalie Contentin, Dominique Bordessoule, Cécile Pautas, Thierry de Revel, Bruno Quesnel et al. · 2010 · Journal of Clinical Oncology
Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use
Zdzisińska, Barbara, Żurek, Aleksandra, Kandefer-Szerszeń, Martyna · 2017 · Archivum Immunologiae et Therapiae Experimentalis
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
de Botton, Stephane, Mondesir, Johanna, Willekens, Christophe, Touat, Mehdi · 2016 · Journal of Blood Medicine
Cancer metabolism in space and time: Beyond the Warburg effect
Pierre Danhier, Piotr Bański, Valéry L. Payen, Debora Grasso, Luigi Ippolito, Pierre Sonveaux, Paolo Ettore Porporato · 2017 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
Lactate dehydrogenase A silencing in IDH mutant gliomas
Chesnelong, Charles, Chaumeil, Myriam M., Blough, Michael D., Al-Najjar, Mohammad, Stechishin, Owen D., Chan, Jennifer A., Pieper, Russell O., Ronen, Sabrina M., Weiss, Samuel, Luchman, H. Artee et al. · 2014 · Neuro-Oncology
Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents
Wang, Pu, Wu, Jing, Ma, Shenghong, Zhang, Lei, Yao, Jun, Hoadley, Katherine A., Wilkerson, Matthew D., Perou, Charles M., Guan, Kun-Liang, Ye, Dan et al. · 2015 · Cell Reports
Isocitrate Dehydrogenase Mutation and ( <i>R</i> )-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development
Dang, Lenny, Su, Shin-San Michael · 2017 · Annual Review of Biochemistry
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
Wen‐Chien Chou, Hsin‐An Hou, Chien‐Yuan Chen, Jih‐Luh Tang, Ming Yao, Woei Tsay, Bor-Shen Ko, Shang‐Ju Wu, Shang‐Yi Huang, Szu-Chun Hsu et al. · 2010 · Blood
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, Shengfang Ge, Peiwei Chai, Ai Zhuang, Xianqun Fan · 2022 · 癌症：英文版
Hypoxia signaling pathways: modulators of oxygen-related organelles
Miriam J. Schönenberger · 2015 · Frontiers in Cell and Developmental Biology
TET proteins and 5‐methylcytosine oxidation in hematological cancers
Myunggon Ko, Jungeun An, William A. Pastor, Sergei B. Koralov, Klaus Rajewsky, Anjana Rao · 2014 · Immunological Reviews
IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status
Susanne Schnittger, Claudia Haferlach, Madlen Ulke, Tamara Alpermann, Wolfgang Kern, Torsten Haferlach · 2010 · Blood
Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair
Yanxin Lu, Jakub Kwintkiewicz, Yang Liu, Katherine Tech, Lauren N. Frady, Yu-Ting Su, Wendy Bautista, Seog In Moon, Jeffrey M. Macdonald, Matthew G. Ewend et al. · 2017 · Cancer Research
SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1 α –Dependent Glycolysis
Guangwei Liu, Yujing Bi, Bo Shen, Hui Yang, Yan Zhang, Xiao Wang, Huanrong Liu, Yun Lu, Jiongbo Liao, Xi Chen et al. · 2013 · Cancer Research
An in vivo patient-derived model of endogenous IDH1-mutant glioma
Hema Artee Luchman, Owen D.M. Stechishin, Nam Hoang Dang, Michael D. Blough, Charles Chesnelong, John J. Kelly, Shaun A. Nguyen, Jennifer Ai-wen Chan, Aalim M. Weljie, J. Greg Cairncross et al. · 2011 · Neuro-Oncology
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia
Courtney Denton Dinardo, KATHLEEN JOY PROPERT, Alison Wakoff Loren, Elisabeth M. Paietta, Zhuoxin Sun, Ross L. Levine, Kimberly S. Straley, Katharine E. Yen, Jay P. Patel, Samuel V. Agresta et al. · 2013 · Blood
Role of mitochondrial alterations in human cancer progression and cancer immunity
Sheng‐Fan Wang, Ling‐Ming Tseng, Hsin‐Chen Lee · 2023 · Journal of Biomedical Science
Targeting histone lysine demethylases — Progress, challenges, and the future
Cyrille C. Thinnes, Katherine S. England, Akane Kawamura, Rasheduzzaman Chowdhury, Christopher John Schofield, Richard J. Hopkinson · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Targeting Metabolic Remodeling in Glioblastoma Multiforme
Amparo Wolf, Sameer Agnihotri, Abhijit Guha · 2010 · Oncotarget
Driver mutations of cancer epigenomes
David M. Roy, Logan A. Walsh, Timothy An-thy Chan · 2014 · Protein & Cell
Glioma Biology and Molecular Markers
Adam Louis Cohen, Howard Colman · 2014 · Cancer treatment and research
IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms
Animesh Dev Pardanani, Terra L. Lasho, Christy M. Finke, Ming Mai, Rebecca F. McClure, Ayalew Tefferi · 2010 · Leukemia
IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group
for the Children’s Oncology Group, Ian F. Pollack, Ronald L. Hamilton, Robert William Sobol, Marina N. Nikiforova, Maureen A. Lyons‐Weiler, William A. LaFramboise, Peter C. Burger, Daniel Jay Brat, Marc K. Rosenblum et al. · 2010 · Child s Nervous System
The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation
Remco Jurriaan Molenaar, Tomas Radivoyevitch, Jaroslaw Pawel Maciejewski, Cornelis J.F. Van Noorden, Fonnet E. Bleeker · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells
M. Cecilia Caino, Young Chan Chae, Valentina Vaira, Stefano Ferrero, Mario Nosotti, Nina Martin, Ashani T. Weeraratna, Michael P. O’Connell, Danielle L. Jernigan, Alessandro Fatatis et al. · 2013 · Journal of Clinical Investigation
Cell metabolism: An essential link between cell growth and apoptosis
Emily Ferguson Mason, Jeffrey C. Rathmell · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Regulation of human metabolism by hypoxia-inducible factor
F. Formenti, D. Constantin-Teodosiu, Yaso Emmanuel, J. Cheeseman, K. Dorrington, L. Edwards, S. Humphreys, T. Lappin, M. McMullin, Christopher J. McNamara et al. · 2010 · Proceedings of the National Academy of Sciences of the United States of America
The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization
Patrick S. Ward, Chao Lü, Justin R. Cross, Omar Ibrahim Abdel-Wahab, Ross L. Levine, Gary K. Schwartz, Craig B. Thompson · 2012 · Journal of Biological Chemistry
Metabolic therapy: A new paradigm for managing malignant brain cancer
Thomas N. Seyfried, Roberto E. Flores, Angela M. Poff, Dominic P. D’Agostino, Purna Mukherjee · 2014 · Cancer Letters
Magnetic Resonance of 2-Hydroxyglutarate in IDH1 -Mutated Low-Grade Gliomas
Adam Elkhaled, Llewellyn E. Jalbert, Joanna J. Phillips, Hikari A. I. Yoshihara, Rupa Parvataneni, Radhika Srinivasan, G. Bourne, Mitchel Stuart Berger, Susan Marina Chang, Soonmee Cha et al. · 2012 · Science Translational Medicine
Redox Potential of Antioxidants in Cancer Progression and Prevention
Sajan George, Heidi Abrahamse · 2020 · Antioxidants
Hypoxia: The Cornerstone of Glioblastoma
Marta Doménech, Ainhoa Hernández, Andrea Plaja, Eva Martinez‐Balibrea, Carmen Balañá · 2021 · International Journal of Molecular Sciences
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
W-C Chou, W-C Lei, Bor‐Sheng Ko, H-A Hou, C-Y Chen, J-L Tang, Ming Yao, Woei Tsay, S-J Wu, S-Y Huang et al. · 2010 · Leukemia
The HIF pathway and erythrocytosis
Lee, Frank S., Percy, Melanie J. · 2011 · Annual Review of Pathology Mechanisms of Disease
Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
Brent A. Orr, Michael C. Haffner, William G. Nelson, Srinivasan Yegnasubramanian, Charles G. Eberhart · 2012 · PLoS ONE
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation
Christopher G. Duncan, Benjamin G. Barwick, Genglin Jin, Carlo Rago, Priya Kapoor-Vazirani, Doris R. Powell, Jen‐Tsan Chi, Darell D. Bigner, Paula M. Vertino, Hai Yan · 2012 · Genome Research
The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations
Andreas von Deimling, Andrey Korshunov, Christian Johannes Hartmann · 2010 · Brain Pathology
Metabolic changes in cancer: beyond the Warburg effect
Wu, Weihua, Zhao, Shimin · 2013 · Acta Biochimica et Biophysica Sinica
Metabolism unhinged: IDH mutations in cancer
John R. Prensner, Arul M. Chinnaiyan · 2011 · Nature Medicine
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F
Ayalew Tefferi, Thitina Jimma, Nanna Helen Sulai, Terra L. Lasho, Christy M. Finke, Ryan A. Knudson, Rebecca F. McClure, Animesh Dev Pardanani · 2011 · Leukemia
Metabolic rewiring in melanoma
Boris I. Ratnikov, David A. Scott, Andrei L. Osterman, Jeffrey W. Smith, Ze’ev A. Ronai · 2016 · Oncogene
What do we know about IDH1/2 mutations so far, and how do we use it?
Craig Horbinski · 2013 · Acta Neuropathologica
Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation
Roberta Leonardi, Chitra Subramanian, Suzanne Jackowski, Charles O. Rock · 2012 · Journal of Biological Chemistry
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
Pei Yang, Wei Zhang, Yinyan Wang, Xiaoxia Peng, Baoshi Chen, Xiaoguang Qiu, Guilin Li, Shouwei Li, Chenxing Wu, Kun Yao et al. · 2015 · Oncotarget
Sensing and Transmitting Intracellular Amino Acid Signals through Reversible Lysine Aminoacylations
Xiadi He, Wei Gong, Jianong Zhang, Ji Nie, Cui-Fang Yao, Fushen Guo, Yan Lin, Xiaohui Wu, Feng Li, Jie Li et al. · 2017 · Cell Metabolism
TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State
Simone Cardaci, Maria Rosa Ciriolo · 2012 · International Journal of Cell Biology
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression
B. Philip, Koichi Ito, Rafael Moreno‐Sánchez, Stephen John Ralph · 2013 · Carcinogenesis
Oncogenic regulation of tumor metabolic reprogramming
Míriam Tarrado‐Castellarnau, Pedro de Atauri, Marta Cascante · 2016 · Oncotarget
Cancer and Altered Metabolism: Potential Importance of Hypoxia-Inducible Factor and 2-Oxoglutarate-Dependent Dioxygenases
Kaelin, W. G. · 2011 · Cold Spring Harbor Symposia on Quantitative Biology
Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update
Benjamin T. Whitfield, Jason T. Huse · 2022 · Brain Pathology
Metabolic consequences of oncogenic IDH mutations
Seth J. Parker, Christian M. Metallo · 2015 · Pharmacology & Therapeutics
Diagnostic Use ofIDH1/2Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma Tissues
Craig Horbinski, Julia Kofler, Lindsey M. Kelly, GEOFFREY H. MURDOCH, Marina N. Nikiforova · 2009 · Journal of Neuropathology & Experimental Neurology
Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation
Lokendra Kumar Sharma, Hezhi Fang, Jiangtao Liu, Rasika S. Vartak, Janice Deng, Yidong Bai · 2011 · Human Molecular Genetics
Clinicopathological relevance of BRAF mutations in human cancer
Pakneshan, Sahar, Salajegheh, Ali, Anthony Smith, Robert, King-Yin Lam, Alfred · 2013 · Pathology
Targeting Energetic Metabolism: A New Frontier in the Pathogenesis and Treatment of Pulmonary Hypertension
Rubin M. Tuder, Laura A. Davis, Brian B. Graham · 2011 · American Journal of Respiratory and Critical Care Medicine
Mutant Metabolic Enzymes Are at the Origin of Gliomas
Hai Yan, Darell D. Bigner, Victor E. Velculescu, Donald Williams Parsons · 2009 · Cancer Research
Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation
Sichen Li, Arthur P. Chou, Weidong Chen, Ruihuan Chen, Yuzhong Deng, HEIDI S. PHILLIPS, Julia M. Selfridge, Mira Zurayk, Jerry J. Lou, Richard G. Everson et al. · 2012 · Neuro-Oncology
Glutamate and α-ketoglutarate: key players in glioma metabolism
Andreas Maus, Godefridus J. Peters · 2016 · Amino Acids
Isocitrate dehydrogenase‐mutant glioma: Evolving clinical and therapeutic implications
Julie J. Miller, Helen Alice Shih, Ovidiu C. Andronesi, Daniel P. Cahill · 2017 · Cancer
The Roles of 2-Hydroxyglutarate
Xin Du, Hai Hu · 2021 · Frontiers in Cell and Developmental Biology
Management of Low-Grade Glioma
Nader Pouratian, David Schiff · 2010 · Current Neurology and Neuroscience Reports
Genetic insights into OXPHOS defect and its role in cancer
Dhyan Chandra, Keshav Kumar Singh · 2010 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives
Yongcheng Song, Fangrui Wu, Jingyu Wu · 2016 · Journal of Hematology & Oncology
Oncometabolites‐driven tumorigenesis: From genetics to targeted therapy
Aurélie Morin, Éric Letouzé, Anne‐Paule Gimenez‐Roqueplo, Judith Favier · 2014 · International Journal of Cancer
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation
Jinlong Shi, Baolan Sun, Wei Shi, Hao Zuo, Daming Cui, Lanchun Ni, Jian Chen · 2014 · Tumor Biology
Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis
Chiara Bardella, Osama Al‐Dalahmah, Daniel Krell, Pijus Brazauskas, Khalid Al‐Qahtani, Markéta Tomková, Julie Adam, Sébastien Serres, Helen E. Lockstone, Luke Freeman-Mills et al. · 2016 · Cancer Cell
Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance
Weihua Zhou, Daniel Richard Wahl · 2019 · Cancers
Radioprotection of <i>IDH1</i> -Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198
Molenaar, Remco J., Botman, Dennis, Smits, Myrthe A., Hira, Vashendriya V., van Lith, Sanne A., Stap, Jan, Henneman, Peter, Khurshed, Mohammed, Lenting, Krissie, Mul, Adri N. et al. · 2015 · Cancer Research
Inborn and acquired metabolic defects in cancer
Christian Frezza, Patrick J. Pollard, Eyal Gottlieb · 2011 · Journal of Molecular Medicine
Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China
Jiang-Han Wang, Wen‐Lian Chen, Junmin Li, Songfang Wu, Tianlu Chen, Yongmei Zhu, Weina Zhang, Yang Li, Yun-Ping Qiu, Ai-Hua Zhao et al. · 2013 · Proceedings of the National Academy of Sciences
Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients
Mrinal M. Patnaik, Curtis A. Hanson, Janice M. Hodnefield, Terra L. Lasho, Christy M. Finke, Ryan A. Knudson, Rhett P. Ketterling, Animesh Dev Pardanani, Ayalew Tefferi · 2011 · Leukemia
Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes
Brian W. Wong, Anna Kuchnio, Ulrike Brüning, Peter Carmeliet · 2012 · Trends in Biochemical Sciences
Oncometabolites: tailoring our genes
Stefan Nowicki, Eyal Gottlieb · 2015 · FEBS Journal
Metabolism and Brain Cancer
Suely Kazue Nagahashi Marie, Sueli Mieko Oba‐Shinjo · 2011 · Clinics
Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling
Laurence M. Gagné, Karine Boulay, Ivan Topisirović, Marc‐Étienne Huot, Frédérick A. Mallette · 2017 · Trends in Cell Biology
Update on molecular findings, management and outcome in low-grade gliomas
T. David Bourne, David Schiff · 2010 · Nature Reviews Neurology
Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
Yukihiko Sonoda, Toshihiro Kumabe, Taigen Nakamura, Ryuta Saito, Masayuki Kanamori, Yoji Yamashita, Hiroyoshi Suzuki, Teiji Tominaga · 2009 · Cancer Science
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
Aalim M. Weljie, Frank Robert Jirik · 2010 · The International Journal of Biochemistry & Cell Biology
IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo
Linda B.C. Bralten, Nanne K. Kloosterhof, Rutger K. Balvers, Andrea Sacchetti, Lariesa Lapre, Martine L.M. Lamfers, Sieger Leenstra, Hugo R. de Jonge, Johan M. Kros, Erwin E. W. Jansen et al. · 2011 · Annals of Neurology
Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics
Burroughs, Sarah K, Kaluz, Stefan, Wang, Danzhu, Wang, Ke, Van Meir, Erwin G, Wang, Binghe · 2013 · Future Medicinal Chemistry
Metabolomic signatures of aggressive prostate cancer
Jonathan E. McDunn, Zhen Li, Klaus‐Peter Adam, Bruce P Neri, Robert L. Wolfert, Michael V. Milburn, Yair Lotan, Thomas M. Wheeler · 2013 · The Prostate
Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (IDH1) via Disruption of a Metal Binding Network by an Allosteric Small Molecule
Gejing Deng, Junqing Shen, Ming Yin, Jessica McManus, Magali Mathieu, Patricia Gee, Timothy He, Chaomei Shi, Olivier Bedel, Larry R. McLean et al. · 2014 · Journal of Biological Chemistry
Critical Enzymatic Functions of FTO in Obesity and Cancer
Xiaolan Deng, Rui Jun Su, Savanna Stanford, Jianjun Chen · 2018 · Frontiers in Endocrinology
The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status
Claire L. Green, Catherine M. Evans, Robert Kerrin Hills, Alan K. Burnett, David C. Linch, Rosemary E. Gale · 2010 · Blood